BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 P&L / Income Statement

BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

651,000,000 US dollars

Cost of goods sold

305,200,000 US dollars

Gross profit

345,800,000 US dollars

Operating expenses (calculated)

273,200,000 US dollars

Segment profit (loss)

72,600,000 US dollars

Other income (expense), net (calculated)

469,500,000 US dollars

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

542,100,000 US dollars

(Provision) benefit for income taxes

170,700,000 US dollars

Net income attributable to Bio-Rad

371,400,000 US dollars

Europe

229,200,000 US dollars

Asia Pacific

121,800,000 US dollars

UNITED STATES

255,500,000 US dollars

Americas

44,500,000 US dollars

Selling, general and administrative expense

212,000,000 US dollars

Research and Development Expense

61,200,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.